Exhibit 31.1
                                  CERTIFICATION

     Pursuant to the requirements of Rules 13a-14 of the Securities Exchange Act
of 1934, as amended, James R. Musick provides the following certification.

     I, James R. Musick, President, Chief Executive Officer, Chairman of the
Board of Directors and Principal Financial Officer of Vitro Diagnostics, Inc.
("Company") certify that:

1.            I have reviewed this quarterly report on Form 10-QSB of the
              Company;

2.            Based on my knowledge, this quarterly report does not contain any
              untrue statement of a material fact or omit to state a material
              fact necessary to make the statements made, in light of the
              circumstances under which such statements were made, not
              misleading with respect to the period covered by this quarterly
              report;

3.            Based on my knowledge, the financial statements, and other
              financial information included in the quarterly report, fairly
              present in all material respects the financial condition, results
              of operations and cash flows of the Company as of, and for, the
              periods presented in this quarterly report;

4.            I am responsible for establishing and maintaining disclosure
              controls and procedures (as defined in Exchange Act Rules 13a-14
              and 15-d-14) for the registrant and have designed such disclosure
              controls and procedures to ensure that material information
              relating to the Company is made know to me by others, particularly
              during the period in which this quarterly report is being
              prepared;

5.            I have disclosed, based on my most recent evaluation, to the
              Company's auditors and the audit committee of our board of
              directors (or persons performing the equivalent functions):

a.            All significant deficiencies in the design or operation of
              internal controls which could adversely affect the Company's
              ability to record, process, summarize and report financial date
              and have identified for the Company's auditors any material
              weaknesses in internal controls, and

b.            Any fraud, whether or not material, that involves management or
              other employees which have a significant role in the Company's
              internal controls; and

6.            I have indicated in this quarterly report whether or not there
              were significant changes in internal control or in other factors
              that could significantly affect internal controls subsequent to
              the date of my most recent evaluation, including any corrective
              actions with regard to significant deficiencies and material
              weaknesses.

Date: June 14, 2007
                                           By: /s/ James R. Musick
                                               -----------------------
                                               James R. Musick, President, Chief
                                               Executive Officer, Chairman of
                                               the Board of Directors, and
                                               Principal Financial Officer